Ernst Hoyer, Utah Medical Products, Inc. (UTMD)’s insider Sold 1,529 Shares; Last Week Heritage Insurance Holdings, Inc. (HRTG) Coverage

Among 7 analysts covering Heritage Insurance Holdings (NYSE:HRTG), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Heritage Insurance Holdings had 18 analyst reports since August 7, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained Heritage Insurance Holdings, Inc. (NYSE:HRTG) rating on Thursday, August 17. Keefe Bruyette & Woods has “Buy” rating and $17.0 target. The firm has “Buy” rating by Sandler O’Neill given on Friday, September 23. The firm has “Buy” rating given on Friday, November 3 by Citigroup. The stock of Heritage Insurance Holdings, Inc. (NYSE:HRTG) has “Buy” rating given on Tuesday, October 17 by Citigroup. The firm has “Buy” rating given on Friday, August 7 by Citigroup. The rating was upgraded by JMP Securities on Tuesday, October 20 to “Market Outperform”. Wood maintained Heritage Insurance Holdings, Inc. (NYSE:HRTG) on Monday, June 13 with “Outperform” rating. The firm earned “Buy” rating on Friday, June 2 by Keefe Bruyette & Woods. The firm earned “Buy” rating on Wednesday, November 1 by SunTrust. The stock of Heritage Insurance Holdings, Inc. (NYSE:HRTG) earned “Hold” rating by JMP Securities on Monday, January 22. See Heritage Insurance Holdings, Inc. (NYSE:HRTG) latest ratings:

22/01/2018 Broker: JMP Securities Rating: Hold Downgrade
21/12/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $21.0 Maintain
04/12/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $20.0 Maintain
03/11/2017 Broker: Citigroup Rating: Buy Old Target: $18 New Target: $19 Maintain
01/11/2017 Broker: SunTrust Rating: Buy New Target: $18.0 Maintain
17/10/2017 Broker: Citigroup Rating: Buy Old Target: $17 New Target: $18 Maintain
26/09/2017 Broker: SunTrust Rating: Buy New Target: $18.0
20/09/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $17.0 Maintain
17/08/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $17.0 Maintain

In an electronic form submitted to the (SEC), it was published that the director of Utah Medical Products Inc Ernst Hoyer, an insider in spotlight, made sold with a broker for 1,529 shares of the stock exchange listed company, worth near $134,673 US Dollars using the average stock value of $88.1 US Dollars. Ernst is trying to silently decrease his company’s share, same as he did in the last month. He unloaded another 49 shares worth $4,459 USD. Ernst Hoyer now indirectly possess 51247 shares. He also directly possess 0 shares. In total he holds a stake of 1.38%.

Heritage Insurance Holdings, Inc., through its subsidiaries, provides personal and commercial residential insurance products. The company has market cap of $427.35 million. The firm offers personal residential insurance for single-family homeowners and condominium owners; rental property insurance; and commercial residential insurance, as well as insurance policies for residential wind insurance in the state of Florida, North Carolina, South Carolina, Hawaii, Georgia, Alabama, and Mississippi. It has a 446.94 P/E ratio. As of December 31, 2016, it had approximately 319,676 personal residential policies and 3,625 commercial residential policies.

The stock decreased 1.59% or $0.26 during the last trading session, reaching $16.09. About 188,800 shares traded. Heritage Insurance Holdings, Inc. (NYSE:HRTG) has declined 6.57% since February 13, 2017 and is downtrending. It has underperformed by 23.27% the S&P500.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide. The company has market cap of $319.97 million. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It has a 37.79 P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

Since February 2, 2018, it had 0 insider purchases, and 1 sale for $4,459 activity. Another trade for 49 shares valued at $4,459 was sold by HOYER ERNST G.